[1] |
李年丰,, 冯思佳. NCCN肝胆肿瘤临床实践指南(2021.V1)胆管肿瘤诊治的解读[J]. 肝胆胰外科杂志, 2021,33(9):513-518.
|
|
LI N F,, FENG S J. Interpretation of NCCN clinical practice guidelines in hepatoliliary cancers (2021, version) for diagnosis and treatment of cholangiocarcinoma[J]. J Hepatopancreatobiliary Surg, 2021,33(9):513-518.
|
[2] |
BANALES J M,, MARIN J J G,, LAMARCA A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management[J]. Nat Rev Gastroenterol Hepatol, 2020,17(9):557-588.
|
[3] |
CHEN P D,, CHEN L J,, CHANG Y J, et al. Long-term survival of combined hepatocellular-cholangiocarcinoma: a nationwide study[J]. Oncologist, 2021,26(10):e1774-e1785.
|
[4] |
RIZVI S,, KHAN S A,, HALLEMEIER C L, et al. Cholangiocarcinoma-evolving concepts and therapeutic strategies[J]. Nat Rev Clin Oncol, 2018,15(2):95-111.
|
[5] |
FERRONE C,, GOYAL L,, QADAN M, et al. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma[J]. Eur J Nucl Med Mol Imaging, 2020,47(8):1871-1884.
|
[6] |
RIBERO D,, ZIMMITTI G,, ALOIA T A, et al. Preoperative cholangitis and future liver remnant volume determine the risk of liver failure in patients undergoing resection for hilar cholangiocarcinoma[J]. J Am Coll Surg, 2016,223(1):87-97.
|
[7] |
CAI Z Y,, HE C B,, ZHAO C Y, et al. Survival comparisons of hepatic arterial infusion chemotherapy with mFOLFOX and transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma[J]. Front Oncol, 2021,11:611118.
|
[8] |
KAWAKAMI H,, KUWATANI M,, ONODERA M, et al. Endoscopic nasobiliary drainage is the most suitable preoperative biliary drainage method in the management of patients with hilar cholangiocarcinoma[J]. J Gastroenterol, 2011,46(2):242-248.
|
[9] |
COELEN R J S,, ROOS E,, WIGGERS J K, et al. Endoscopic versus percutaneous biliary drainage in patients with resectable perihilar cholangiocarcinoma: a multicentre, randomised controlled trial[J]. Lancet Gastroenterol Hepatol, 2018,3(10):681-690.
|
[10] |
MAEDA T,, EBATA T,, YOKOYAMA Y, et al. Preoperative course of patients undergoing endoscopic nasobiliary drainage during the management of resectable perihilar cholangiocarcinoma[J]. J Hepatobiliary Pancreat Sci, 2019,26(8):341-347.
|
[11] |
KAWASHIMA H,, HIROOKA Y,, OHNO E, et al. Effectiveness of a modified 6-Fr endoscopic nasobiliary drainage catheter for patients with preoperative perihilar cholangiocarcinoma[J]. Endosc Int Open, 2018,6(8):E1020-E1030.
|
[12] |
NAKAMURA S,, ISHII Y,, SERIKAWA M, et al. Utility of the inside stent as a preoperative biliary drainage method for patients with malignant perihilar biliary stricture[J]. J Hepatobiliary Pancreat Sci, 2021,28(10):864-873.
|
[13] |
KHAN S A,, DAVIDSON B R,, GOLDIN R D, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update[J]. Gut, 2012,61(12):1657-1669.
|
[14] |
ANDERLONI A,, FUGAZZA A,, TRONCONE E, et al. Single-stage EUS-guided choledochoduodenostomy using a lumen-apposing metal stent for malignant distal biliary obstruction[J]. Gastrointest Endosc, 2019,89(1):69-76.
|
[15] |
中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 肝癌电子杂志, 2020,7(1):5-23.
|
|
Medical Administration of the State Health Commission of the People’s Republic of China. Standard for diagnosis and treatment of primary liver cancer (2019 edition)[J]. Electron J Liver Cancer, 2020,7(1):5-23.
|
[16] |
HAN K,, KO H K,, KIM K W, et al. Radiofrequency ablation in the treatment of unresectable intrahepatic cholangiocarcinoma: systematic review and meta-analysis[J]. J Vasc Interv Radiol, 2015,26(7):943-948.
|
[17] |
GAO D J,, YANG J F,, MA S R, et al. Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial[J]. Gastrointest Endosc, 2021, 94(1): 91-100.e2.
|
[18] |
QI S,, YAN H. Effect of percutaneous transhepatic cholangial drainag + radiofrequency ablation combined with biliary stent implantation on the liver function of patients with cholangiocarcinoma complicated with malignant obstructive jaundice[J]. Am J Transl Res, 2021,13(3):1817-1824.
|
[19] |
XIA M X,, WANG S P,, YUAN J G, et al. Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: a large cohort study[J]. J Hepatobiliary Pancreat Sci, 2021.[Online ahead of print].
|
[20] |
PEREIRA P,, SANTOS A L,, MORAIS R, et al. Endoscopic radiofrequency ablation for palliative treatment of hilar cholangiocarcinoma[J]. VideoGIE, 2021,6(4):195-198.
|
[21] |
INOUE T,, ITO K,, YONEDA M. Novel balloon catheter-based endobiliary radiofrequency ablation system: ex-vivo experimental study[J]. Dig Endosc, 2020,32(6):974-978.
|
[22] |
CILLO U,, FONDEVILA C,, DONADON M, et al. Surgery for cholangiocarcinoma[J]. Liver Int, 2019: 143-155.
|
[23] |
LIN J,, WU A L,, TENG F, et al. Stent insertion for inoperable hilar cholangiocarcinoma: comparison of radioactive and normal stenting[J]. Medicine (Baltimore), 2021,100(21):e26192.
|
[24] |
何湛. PTCD途径胆道金属支架置入术联合放疗在胆管癌患者中的应用效果分析[J]. 浙江创伤外科, 2019,24(1):176-177.
|
|
HE Z. Effect of PTCD biliary metallic stent implantation combined with radiotherapy in patients with cholangiocarcinoma[J]. Zhejiang J Trauma Surg, 2019,24(1):176-177.
|
[25] |
WANG Y,, MAN Z R,, HU X S, et al. Percutaneous biliary stent with intraluminal brachytherapy versus palliative surgery in the management of extrahepatic cholangiocarcinoma[J]. Int J Clin Oncol, 2021,26(5):933-940.
|
[26] |
侯喜山. 胆管支架联合碘( 125I)粒子植入介入治疗恶性梗阻性黄疸的临床分析 [J]. 基层医学论坛, 2019,23(32):4637-4638.
|
|
HOU X S. Clinical analysis of biliary stent combined with iodine ( 125I) seed implantation in interventional treatment of malignant obstructive jaundice [J]. Med Forum, 2019,23(32):4637-4638.
|
[27] |
LEE J,, YOON W S,, KOOM W S, et al. Efficacy of stereotactic body radiotherapy for unresectable or recurrent cholangiocarcinoma: a meta-analysis and systematic review[J]. Strahlenther Onkol, 2019,195(2):93-102.
|
[28] |
HORGAN A M,, KNOX J J. Adjuvant therapy for biliary tract cancers[J]. J Oncol Pract, 2018,14(12):701-708.
|
[29] |
BAAK R,, WILLEMSSEN F E J A,, VAN NORDEN Y, et al. Stereotactic body radiation therapy after chemotherapy for unresectable perihilar cholangiocarcinoma: the STRONG trial, a phase Ⅰ safety and feasibility study[J]. Cancers (Basel), 2021,13(16):3991.
|
[30] |
WANG Y B,, RONG P H,, FU Y F, et al. Stent with radioactive strand insertion for inoperable hilar cholangiocarcinoma: comparison of unilateral and bilateral insertion[J]. Scand J Gastroenterol, 2021,56(12):1473-1479.
|
[31] |
KIM J Y,, LEE S G,, KANG D, et al. The comparison of endoscopic biliary drainage in malignant hilar obstruction by cholangiocarcinoma: bilateral metal stents versus multiple plastic stents[J]. Gut Liver, 2021,15(6):922-929.
|
[32] |
EDELINE J,, TOUCHEFEU Y,, GUIU B, et al. Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial[J]. JAMA Oncol, 2020,6(1):51-59.
|
[33] |
PAPROTTKA K J,, GALIÈ F,, INGRISCH M, et al. Outcome and safety after 103 radioembolizations with yttrium-90 resin microspheres in 73 patients with unresectable intrahepatic cholangiocarcinoma-an evaluation of predictors[J]. Cancers (Basel), 2021,13(21):5399.
|
[34] |
GAIRING S J,, THOL F,, MÜLLER L, et al. The addition of transarterial chemoembolization to palliative chemotherapy extends survival in intrahepatic cholangiocarcinoma[J]. J Clin Med, 2021,10(12):2732.
|
[35] |
YANG L D,, SHAN J,, SHAN L, et al. Trans-arterial embolisation therapies for unresectable intrahepatic cholangiocarcinoma: a systematic review[J]. J Gastrointest Oncol, 2015,6(5):570-588.
|
[36] |
MA K W,, CHEUNG T T,, LEUNG B, et al. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma: a meta-analysis[J]. Medicine (Baltimore), 2019,98(5):e14013.
|
[37] |
FULLER C D,, WANG S J,, CHOI M, et al. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis[J]. Cancer, 2009,115(22):5175-5183.
|
[38] |
CHOI J H,, OH D,, LEE J H, et al. Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheter[J]. Endoscopy, 2015,47(11):1035-1038.
|
[39] |
LI Z Y,, JIANG X F,, XIAO H, et al. Long-term results of ERCP- or PTCS-directed photodynamic therapy for unresectable hilar cholangiocarcinoma[J]. Surg Endosc, 2021,35(10):5655-5664.
|
[40] |
MOHAN B P,, CHANDAN S,, KHAN S R, et al. Photodynamic therapy (PDT), radiofrequency ablation (RFA) with biliary stents in palliative treatment of unresectable extrahepatic cholangiocarcinoma: a systematic review and meta-analysis[J]. J Clin Gastroenterol, 2021.[Online ahead of print].
|
[41] |
LI T,, XU W H,, LIU C, et al. Anticancer effect of biodegradable magnesium on hepatobiliary carcinoma: an in vitro and in vivo study[J]. ACS Biomater Sci Eng, 2021,7(6):2774-2782.
|
[42] |
BATEMAN A C. Immune checkpoint inhibitor therapy in colorectal cancer-the role of cellular pathology[J]. Int J Surg Pathol, 2021,29(6):584-591.
|
[43] |
BARTSCH F,, EBERHARD J,, RÜCKERT F, et al. Repeated resection for recurrent intrahepatic cholangiocarcinoma: a retrospective German multicentre study[J]. Liver Int, 2021,41(1):180-191.
|